financetom
Business
financetom
/
Business
/
BRIEF-Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement
Jul 22, 2024 5:42 AM

July 22 (Reuters) - Hepion Pharmaceuticals Inc ( HEPA ):

* PHARMA TWO B ANNOUNCES PLANS TO GO PUBLIC VIA MERGER WITH

HEPION

PHARMACEUTICALS, INC. AND CONCURRENT $11.5 MILLION PRIVATE

PLACEMENT

* HEPION PHARMACEUTICALS INC ( HEPA ): CURRENT PHARMA TWO B

EQUITY-HOLDERS

WILL OWN ABOUT 85% OF COMBINED COMPANY

* HEPION PHARMACEUTICALS ( HEPA ) : CURRENT HEPION EQUITY-HOLDERS

WILL OWN

ABOUT 15% OF COMBINED COMPANY

* HEPION PHARMACEUTICALS ( HEPA )- ENTERED PURCHASE DEAL WITH

INSTITUTIONAL

INVESTORS FOR SALE OF $2.9 MILLION SENIOR UNSECURED NOTE

* HEPION PHARMACEUTICALS INC ( HEPA ): PROPOSED DEAL FOR $58.5

MILLION

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Ford's Michigan Battery Plant Set for Tax Credit Under Trump's Final Bill
Market Chatter: Ford's Michigan Battery Plant Set for Tax Credit Under Trump's Final Bill
Jul 8, 2025
01:15 PM EDT, 07/08/2025 (MT Newswires) -- Ford Motor's ( F ) battery facility under construction in Marshall, Michigan, is on course to qualify for a production tax credit, Bloomberg reported Tuesday, citing a company statement. Executive Chair Bill Ford said in May the plant was imperiled by language in President Donald Trump's $3.4 trillion fiscal bill, which would have...
Quantum BioPharma Up After Submitting its Candidate for Multiple Sclerosis Drug for Fast-Track Program in the UK
Quantum BioPharma Up After Submitting its Candidate for Multiple Sclerosis Drug for Fast-Track Program in the UK
Jul 8, 2025
01:49 PM EDT, 07/08/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) shares were last seen up 4.7% after the company on Tuesday submitted its patented candidate breakthrough drug, Lucid-21-302, a new, first-in-class treatment for multiple sclerosis (MS), to the Innovative Licensing and Access Pathway (ILAP) Passport program in the United Kingdom, through its unit, Huge Biopharma Australia. The ILAP...
--Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs
--Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs
Jul 8, 2025
01:47 PM EDT, 07/08/2025 (MT Newswires) -- Price: 25.49, Change: +0.25, Percent Change: +0.99 ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved